Chartwell Pharmaceuticals
Sean Cotter has extensive work experience in the pharmaceutical industry. Sean began their career at Pfizer in 2003, working in the Programme Management Office until 2006. Sean then moved on to Amgen, where they served as the Director of Risk Management from 2007 to 2014. In 2015, they joined Mallinckrodt Pharmaceuticals as the Senior Director of Strategic Enterprise Risk Management. Most recently, Sean worked at Chartwell Pharmaceuticals as the Executive Vice President of Corporate Quality starting in 2017.
Sean Cotter holds a PhD in Organic Chemistry from University College Cork. Sean also has a Masters degree in Financial Risk Management from NYU Stern School of Business. Furthermore, they obtained a Masters degree in Technology Management from University College Dublin.
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.